Tea, coffee and prostate cancer

Molecular Nutrition and Food Research

Volumn 53, Issue 2, 2009, Pages 256-265

  Lee, Andy H ^a   Fraser, Michelle L ^a   Binns, Colin W ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Coffee; Dietary guidelines; Epidemiologic studies; Prostate cancer; Tea

Indexed keywords

ANIMAL; ANIMAL MODEL; CLINICAL TRIAL; COFFEE; HUMAN; MALE; PROSTATE TUMOR; REVIEW; TEA;

ANIMALS; CLINICAL TRIALS AS TOPIC; COFFEE; HUMANS; MALE; MODELS, ANIMAL; PROSTATIC NEOPLASMS; TEA;

ANIMALIA;

EID: 60849093749     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800218     Document Type: Review

References (96)

1. World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, AICR, Washington DC 2007.
2. Stewart, B. W, Kleihues, P., World Cancer Report, International Agency for Research on Cancer, Lyon 2003.
3. Li, X. M., Ganmaa, D., Qin, L. Q., Liu, X. F., et al., The effects of estrogen-like products in milk on prostate and testes, Zhonghua Nan Ke Xue 2003, 9, 186-90.
4. Australian Institute of Health and Welfare (AIHW) & Australasian Association of Cancer Registries (AACR), Cancer in Australia 2001, AIHW cat. no. CAN 23, AIHW, Canberra 2001.
5. Higdon, J. V., Frei, B., Coffee and health: A review of recent human research, Crit. Rev. Food Sci. Nutr. 2006, 46, 101-123.
6. Setiawan, V. W., Zhang, Z. F., Yu, G. P., Lu, Q. Y., et al., Protective effect of green tea on the risks of chronic gastritis and stomach cancer, Int. J Cancer 2001, 92, 600 - 604.
7. Su, L. J., Arab, L., Tea consumption and the reduced risk of colon cancer - results from a national prospective cohort study, Public Health Nutr. 2002, 5, 419-425.
8. Yuan, J. M., Gao, Y. T., Yang, C. S., Yu, M. C., Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study, Int. J Cancer 2007, 120, 1344-1350.
9. Hakim, I. A., Harris, R. B., Weisgerber, U. M., Tea intake and squamous cell carcinoma of the skin: Influence of type of tea beverages, Cancer Epidemiol. Biomarkers Prev. 2000, 9, 727-731.
10. Rees, J. R., Stukel, T A., Perry, A. E., Zens, M. S., et al., Tea consumption and basal cell and squamous cell skin cancer: Results of a case-control study, J Am. Acad. Dermatol. 2007, 56, 781-785.
11. Wu, A. H., Yu, M. C., Tseng, C. C., Hankin, J., et al., Green tea and risk of breast cancer in Asian Americans, Int. J Cancer 2003, 106, 514-519.
12. Inoue, M., Tajima, K., Mizutani, M., Iwata, H., et al., Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC), Japan, Cancer Lett. 2001,167,175-182.
13. Zhang, M., Holman, C. D., Huang, J. P., Xie, X., Green tea and the prevention of breast cancer: A case-control study in southeast China, Carcinogenesis 2007, 28, 1074-1078.
14. Nagano, I., Kono, S., Preston, D. L., Mabuchi, K., A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan), Cancer Causes Control 2001, 12, 501-508.
15. Lee, A. H., Fraser, M. L., Meng, X., Binns, C. W., Protective effects of green tea against prostate cancer, Expert Rev. Anticancer Ther. 2006, 6, 507-513.
16. Jian, L., Xie, L. P., Lee, A. H., Binns, C. W., Protective effect of green tea against prostate cancer: A case-control study in southeast China, Int. J Cancer 2004, 108, 130-135.
17. Grigg, D., The worlds of tea and coffee: Patterns of consumption, Geojournal 2002, 57, 283-294.
18. Cheung, E., Wadhera, P., Dorff, T., Pinski, J., Diet and prostate cancer risk reduction, Expert Rev. Anticancer Ther. 2008, 8, 43-50.
19. Syed, D. N., Khan, N., Afaq, F., Mukhtar, H., Chemoprevention of prostate cancer through dietary agents: Progress and promise, Cancer Epidemiol. Biomarkers Prev. 2007, 16, 2193-2203.
20. Gupta, S., Prostate cancer chemoprevention: current status and future prospects, Toxicol. Appl. Pharmacol. 2007, 224, 369-316.
21. National Health and Medical Research Council, A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines, NHMRC, Canberra 1999.
22. Australian Bureau of Statistics, Apparent Consumption of Foodstuffs: Australia, ABS, Canberra 2000.
23. Mukhtar, H., Ahmad, N., Tea polyphenols: Prevention of cancer and optimizing health, Am. J. Clin. Nutr. 2000, 71, 1698S-1702S.
24. Graham, H. N., Green tea composition, consumption, and polyphenol chemistry, Prev. Med. 1992, 21, 334-350.
25. Nawrot, R, Jordan, S., Eastwood, J., Rotstein, J., et al., Effects of caffeine on human health, Food Addit. Contam. 2003, 20, 1-30.
26. Iwai, K., Kishimoto, N., Kakino, Y, Mochida, K., et al., In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans, J Agrie. Food Chem. 2004, 52, 4893-4898.
27. MacMahon, B., Yen, S., Trichopoulos, D., Warren, K., et al., Coffee and cancer of the pancreas, N. Engl. J. Med. 1981, 304, 630-633.
28. Miller, D. R., Rosenberg, L., Kaufman, D. W., Helmrich, S. P., et al., Epithelial ovarian cancer and coffee drinking, Int. J. Epidemiol. 1987, 16, 13-17.
29. Chen, Y. C., Chiang, C. I., Lin, R. S., Pu, Y. S., et al., Diet, vegetarian food and prostate carcinoma among men in Taiwan, Br. J Cancer 2005, 93, 1057-1061.
30. Sharpe, G R., Siemiatycki, I, Consumption of non-alcoholic beverages and prostate cancer risk, Eur. J. Cancer Prev. 2002, 11, 497-501.
31. Hsieh, C. C., Thanos, A., Mitropoulos, D., Deliveliotis, C., et al, Risk factors for prostate cancer: A case-control study in Greece, Int. J Cancer 1999, 80, 699-703.
32. Villeneuve, P. J., Johnson, K. C., Kreiger, N., Mao, Y., Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group, Cancer Causes Control 1999, 10, 355-367.
33. Jain, M. G., Hislop, G. T., Howe, G. R., Burch, J. D., et al., Alcohol and other beverage use and prostate cancer risk among Canadian men, Int. J Cancer 1998, 75, 707-711.
34. Gronberg, H., Damber, L., Damber, J. E., Total food consumption and body mass index in relation to prostate cancer risk: A case-control study in Sweden with prospectively collected exposure data, J Urol. 1996, 155, 969-974.
35. Slattery, M. L., West, D. W, Smoking, alcohol, coffee, tea, caffeine, and theobromine: Risk of prostate cancer in Utah (United States), Cancer Causes Control 1993, 4, 559-563.
36. Ellison, L. F., Tea and other beverage consumption and prostate cancer risk: A Canadian retrospective cohort study, Eur. J CancerPrev. 2000, 9, 125-130.
37. Le Marchand, L., Kolonel, L. N., Wilkens, L. R., Myers, B. G, et al, Animal fat consumption and prostate cancer: A prospective study in Hawaii, Epidemiology 1994, 5, 276-282.
38. Severson, R. K., Nomura, A. M., Grove, J. S., Stemmermann, G. N., A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii, Cancer Res. 1989, 49, 1857-1860.
39. Nomura, A., Heilbrun, L. K., Stemmermann, G. N., Prospective study of coffee consumption and the risk of cancer, J. Natl. Cancer Inst. 1986, 76, 587-590.
40. Hsing, A. W, McLaughlin, J. K., Schuman, L. M., Bjelke, E., et al., Diet, tobacco use, and fatal prostate cancer: Results from the Lutheran Brotherhood Cohort Study, Cancer Res. 1990, 50, 6836-6840.
41. Phillips, R. L., Snowdon, D. A., Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: Preliminary results, Cancer Res. 1983, 43, 2403s-2408s.
42. McCusker, R. R., Goldberger, B. A., Cone, E. J., Caffeine content of specialty coffees, J. Anal. Toxicol. 2003, 27, 520-522.
43. Hashimoto, T., He, Z., Ma, W. Y., Schmid, P. C., et al., Caffeine inhibits cell proliferation by G0/G1 phase arrest in JB6 cells, Cancer Res. 2004, 64, 3344-3349.
44. Lee, W. J., Zhu, B. T., Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechoi-containing coffee polyphenols, Carcinogenesis 2006, 27, 269-277.
45. Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., et al., Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity, Food Chem. Toxicol. 2002, 40, 1155-1163.
46. Porta, M., Vioque, I, Ayude, D., Alguacil, J., et al., Coffee drinking: The rationale for treating it as a potential effect modifier of carcinogenic exposures, Eur. J. Epidemiol. 2003, 18, 289-298.
47. Efferth, T., Fabry, U., Glatte, P., Osieka, R., Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells, J. Cancer Res. Clin. Oncol. 1995, 121, 648-656.
48. Link, C. J. Jr., Evans, M. K., Cook, J. A., Muldoon, R., et al., Caffeine inhibits gene-specific repair of UV-induced DNA damage in hamster cells and in human xeroderma pigmentosum group C cells, Carcinogenesis 1995, 16, 1149-1155.
49. Porta, M., Malats, N., Guarner, L., Carrato, A., et al., Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRASII Study Group, J. Epidemiol. Community Health 1999, 53, 702-709.
50. Miura, Y., Ono, K., Okauchi, R., Yagasaki, K., Inhibitory effect of coffee on hepatoma proliferation and invasion in culture and on tumor growth, metastasis and abnormal lipoprotein profiles in hepatoma-bearing rats, J. Nutr. Sci. Vitaminol. (Tokyo) 2004, 50, 38-44.
51. La Vecchia, C., Tavani, A., Coffee and cancer risk: An update,Eur. J CancerPrev. 2007, 16, 385-389.
52. US Food and Drug Administration, Letter responding to health claim petition dated January 27, 2004: Green tea and reduced risk of cancer health claim, Center for Food Safety and Applied Nutrition, Department of Health and Human Services; http://www.cfsan.fda.gov/~dms/qhc-gtea.html, 2004.
53. Sonoda, T., Nagata, Y., Mori, M., Miyanaga, N. et al., A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet, Cancer Sci. 2004, 95, 238-242.
54. Kurahashi, N., Sasazuki, S., Iwasaki, M., Inoue, M., et al., Green tea consumption and prostate cancer risk in Japanese men: A prospective study, Am. J. Epidemiol. 2008, 167, 71-77.
55. Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., et al., Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study, Cancer Res. 2006, 66, 1234-1240.
56. Choan, E., Segal, R., Jonker, D., Malone, S., et al., A prospective clinical trial of green tea for hormone refractory prostate cancer: An evaluation of the complementary/alternative therapy approach, Urol. Oncol. 2005, 23, 108-113.
57. Caporali, A., Davalli, P., Astancolle, S., D'Area, D., et al., The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression, Carcinogenesis 2004, 25, 2217-2224.
58. Kikuchi, N., Ohmori, K., Shimazu, T., Nakaya, N., et al., No association between green tea and prostate cancer risk in Japanese men: The Ohsaki Cohort Study, Br. J. Cancer 2006, 95, 371-373.
59. Heilbrun, L. K., Nomura, A., Stemmermann, G. N., Black tea consumption and cancer risk: A prospective study, Br. J. Cancer 1986, 54, 677-683.
60. Kinlen, L. J., Willows, A. N., Goldblatt, P., Yudkin, J., Tea consumption and cancer, Br. J. Cancer 1988, 55, 397-401.
61. La Vecchia, G., Negri, E., Franceschi, S., D'Avanzo, B., et al., Tea consumption and cancer risk, Nutr. Cancer 1992, 17, 27-31.
62. Gupta, S., Hastak, K., Ahmad, N., Lewin, J. S., et al., Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols, Proc. Natl. Acad. Sci. USA 2001, 95, 10350-10355.
63. Saleem, M., Adhami, V. M., Siddiqui, I. A., Mukhtar, H., Tea beverage in chemoprevention of prostate cancer: A mini-review, Nutr. Cancer 2003, 47, 13-23.
64. Siddiqui, I. A., Raisuddin, S., Shukla, Y, Protective effects of black tea extract on testosterone induced oxidative damage in prostate, Cancer Lett. 2005, 227, 125-132.
65. Siddiqui, I. A., Zaman, N., Aziz, M. H., Reagan-Shaw, S. R. et al., Inhibition of CWR22Rnu1 tumor growth and PSA secretion in athymic nude mice by green and black teas, Carcinogenesis 2006, 27, 833-839.
66. Adhami, V M., Mukhtar, H., Polyphenols from green tea and pomegranate for prevention of prostate cancer, Free Radic. Res. 2006, 40, 1095-1104.
67. Anderson, R. F., Fisher, L. J., Hara, Y., Harris, T., et al., Green tea catechins partially protect DNA from (.)OH radical-induced strand breaks and base damage through fast chemical repair of DNA radicals, Carcinogenesis 2001, 22, 1189-1193.
68. Adhami, V M., Ahmad, N., Mukhtar, H., Molecular targets for green tea in prostate cancer prevention, J. Nutr. 2003, 133, 2417S-2424S.
69. Gupta, S., Ahmad, N., Nieminen, A. L., Mukhtar, H., Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells, Toxicol. Appl. Pharmacol. 2000, 164, 82-90.
70. Hastak, K., Agarwal, M. K., Mukhtar, H., Agarwal, M. L., Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate, FASEB J. 2005, 19, 789-791.
71. Hastak, K., Gupta, S., Ahmad, N., Agarwal, M. K., et al., Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells, Oncogene 2003, 22, 4851-4859.
72. Park, O. J., Surh, Y. J., Chemopreventive potential of epigallocatechin gállate and genistein: Evidence from epidemiological and laboratory studies, Toxicol. Lett. 2004, 150, 43-56.
73. Nam, S., Smith, D. M., Dou, Q. P., Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo, J.Biol. Chem. 2001, 276, 13322-13330.
74. Wang, S. I., Mukhtar, H., Gene expression profile in human prostate LNCaP cancer cells by (-) epigallocatechin-3-gallate, Cancer Lett. 2002, 182, 43-51.
75. Hiipakka, R. A., Zhang, H. Z., Dai, W, Dai, Q., et al., Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols, Biochem. Pharmacol. 2002, 63, 1165-1176.
76. Brusselmans, K., De Schrijver, E., Heyns, W., Verhoeven, G., et al., Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells, Int. J Cancer 2003, 106, 856-862.
77. Gupta, S., Ahmad, N., Mohan, R. R., Husain, M. M., et al., Prostate cancer chemoprevention by green tea: In vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase, Cancer Res. 1999, 59, 2115-2120.
78. Lin, Y L., Lin, J. K., (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB, Mol. Pharmacol. 1991, 52, 465-472.
79. Chung, L. Y., Cheung, T. C., Kong, S. K., Fung, K. P., et al., Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells, Life Sci. 2001, 68, 1207-1214.
80. Demeule, M., Brossard, M., Page, M., Gingras, D., et al., Matrix metalloproteinase inhibition by green tea catechins, Biochim. Biophys. Acta 2000, 1478, 51-60.
81. Albrecht, D. S., Clubbs, E. A., Ferruzzi, M., Bomser, J. A., Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation, Chem. Biol. Interact. 2008, 171, 89-95.
82. Sudano, I., Binggeli, C., Spieker, L., Luscher, T. F., et al., Cardiovascular effects of coffee: Is it a risk factor? Prog. Cardiovasc. Nurs. 2005,20, 65-69.
83. Jee, S. H., He, J., Whelton, P. K., Suh, I., et al., The effect of chronic coffee drinking on blood pressure: A meta-analysis of controlled clinical trials, Hypertension 1999, 33, 647-652.
84. Noordzij, M., Uiterwaal, G S., Arends, L. R., Kok, F. J., et al., Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials, J. Hypertens. 2005, 23, 921-928.
85. Borrelli, F., Capasso, R., Russo, A., Ernst, E., Systematic review: Green tea and gastrointestinal cancer risk, Aliment. Pharmacol. Ther. 2004, 19, 497-510.
86. Sun, C. L., Yuan, J. M., Koh, W. P., Yu, M. C., Green tea, black tea and breast cancer risk: A meta-analysis of epidemiological studies, Carcinogenesis 2006, 27, 1310-1315.
87. Seely, D., Mills, E. J., Wu, P., Verma, S., et al., The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: A systematic review and meta-analysis, Integr. Cancer Ther. 2005, 4, 144-155.
88. Peters, U., Poole, C., Arab, L., Does tea affect cardiovascular disease? A meta-analysis, Am. J. Epidemiol. 2001, 154, 495-503.
89. Kuriyama, S., Shimazu, T., Ohmori, K., Kikuchi, N., et al., Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: The Ohsaki study, JAMA 2006, 296, 1255-1265.
90. Shimazu, T., Kuriyama, S., Hozawa, A., Ohmori, K., et al., Dietary patterns and cardiovascular disease mortality in Japan: A prospective cohort study, Int. J. Epidemiol. 2007, 36, 600-609.
91. Fleshner, N., Zlotta, A. R., Prostate cancer prevention: past, present, and future, Cancer 2007, 110, 1889-1899.
92. Henning, S. M., Fajardo-Lira, C., Lee, H. W., Youssefian, A. A., et al., Catechin content of 18 teas and a green tea extract supplement correlates with the antioxidant capacity, Nutr. Cancer 2003, 45, 226-235.
93. Crespy, V., Williamson, G., A review of the health effects of green tea catechins in in vivo animal models, J. Nutr. 2004, 134, 3431S-3440S.
94. Chow, H. H., Hakim, I. A., Vining, D. R., Crowell, J. A., et al, Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals, Clin. Cancer Res. 2005, 11, 4627-4633.
95. Kroke, A., Boeing, H., Rossnagel, K., Willich, S. N., History of the concept of "levels of evidence" and their current status in relation to primary prevention through lifestyle interventions, Public Health Nutr. 2004, 7, 279-284.
96. Binns, C. W., Lee, M. K., Translating nutrition science into dietary guidelines: Evidence and benchmarking, J. Korean Dietetics Assoc. 2001, 17, 202-207.